The Biotech That Has Almost Doubled in 2017 With the Potential to Boom Even More Post author:Sam Post published:November 21, 2017 Post category:BioPharma Keith Speights, writing for The Motley Fool, notes one biotech that’s booming. Source: BioSpace You Might Also Like ProQR Therapeutics Spins Out CNS-Focused Biotech, September 11, 2017 HEALTHSOUTH Reports Strong Revenue And Earnings Growth For Fourth Quarter 2016 And Reiterates Full-Year 2017 Guidance February 21, 2017 Autonomic Tech Announces Expanded Indication In Europe (CE Mark) For Disabling Migraine With Pulsante SPG Microstimulator System March 9, 2017
HEALTHSOUTH Reports Strong Revenue And Earnings Growth For Fourth Quarter 2016 And Reiterates Full-Year 2017 Guidance February 21, 2017
Autonomic Tech Announces Expanded Indication In Europe (CE Mark) For Disabling Migraine With Pulsante SPG Microstimulator System March 9, 2017
